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The reprogramming of retinal pigment epithelium (RPE) cells in the adult newt immediately after retinal
injury is an area of active research for the study of retinal disorders and regeneration. We demonstrate here
that unlike embryonic/larval retinal regeneration, adult newt RPE cells are not directly reprogrammed into
retinal stem/progenitor cells; instead, they are programmed into a unique state of multipotency that is
similar to the early optic vesicle (embryo) but preserves certain adult characteristics. These cells then
differentiate into two populations from which the prospective-neural retina and -RPE layers are formed
with the correct polarity. Furthermore, our findings provide insight into the similarity between these unique
multipotent cells in newts and those implicated in retinal disorders, such as proliferative vitreoretinopathy,
in humans. These findings provide a foundation for biomedical approaches that aim to induce retinal
self-regeneration for the treatment of RPE-mediated retinal disorders.
D
uring development, the neural retina (NR) and retinal pigment epithelium (RPE) originate from a
common cell source, i.e., neuroepithelial cells of the early optic vesicle, and this differentiation is indis-
pensable for proper vision. In the adult stage, the RPE is located between the NR and the choroid and has a
highly specialised morphology as well as physiological function1,2. Mature RPE cells are, as a rule, mitotically
quiescent, but when the NR suffers traumatic injury, these cells lose their epithelial characteristics and undergo
proliferation and transformation. In humans, this change in RPE cells, categorised as epithelial-mesenchymal
transition (EMT), is responsible for retinal disorders, such as proliferative vitreoretinopathy (PVR)3. Recently, it
was demonstrated that human RPE cells can be reprogrammed into multipotent cells, termed RPE stem cells
(RPESCs), which preferably produce mesenchymal cells, such as myofibroblasts, and RPE cells and contribute to
PVR4. By contrast, in certain urodele amphibians such as the newt, a similar change in RPE cells (termed
transdifferentiation) enables regeneration of an entire retina3. Thus, newt retinal regeneration can serve as a
good model system for comparison with RPE-mediated retinal disorders in humans, and such studies will
contribute to the development of medical treatments targeting in vivo retinal regeneration.
In the adult newt, when the NR is completely removed from the eye via surgery (i.e., retinectomy), the retina is
regenerated from two cell sources5,6; the primary cell source is the RPE, which regenerates the NR and renews the
RPE, and the secondary source is retinal stem/progenitor cells, which are present in the ciliary marginal zone
(CMZ) starting at the embryonic stage. These cells extend toward the central retina along the RPE and participate
in regeneration of the peripheral portion of theNR. Therefore, by eliminating the peripheral retina, it is possible to
focus on retinal regeneration that originates solely from the RPE. We previously described this process using a
Japanese fire bellied newt, Cynops pyrrhogaster5,6 (see Supplementary Movie 1). Upon retinectomy, RPE cells are
detached from each other as well as from the basement membrane (Bruch’s membrane), re-enter the cell cycle,
and form cell aggregates [Stage E-1; this event occurs typically between days 5 and 10 post-operation (po). Almost
all of the RPE-derived cells at this stage have entered the S-phase of the cell cycle, but they do not proceed into the
M-phase. Note that upon retinectomy, the volume of the vitreous cavity decreases and Bruch’s membrane, which
lies along the RPE, becomes folded because blood vessels in the choroid dilate, allowing increased blood flow as an
inflammatory-like response]. The RPE-derived cells generate two rudimentary layers (pro-NR and pro-RPE) for
the prospective NR and RPE tissues [Stage E-2; day 14 po; both cell layers at this stage have partially lost melanin
pigmentation, and cell division becomes obvious from this stage. Note that both the volume of the vitreous cavity
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and the shape of Bruch’s membrane almost completely recover
between Stages E-1 and E-2]. Cells in the pro-RPE layer exit the cell
cycle and re-initiate pigmentation, whereas those in the pro-NR layer
continue to proliferate [Stage E-3; day 19 po; immunoreactivity (IR)
to RPE65 (a marker for terminally differentiated RPE cells) in both
layers decreases sharply from this stage]. Thereafter, the RPE layer
matures (from approximately day 28 po, RPE65-IR re-appears and
microvilli begin to extend) while a new NR is formed (neuronal cell
differentiation and network construction are almost complete
between days 45 and 65 po).
Thus, in this system, RPE-derived cells preserve pigmentation and
RPE65 protein expression until Stage E-35. However, because almost
all of the RPE-derived cells at Stage E-1, which seem homogeneous
with respect to their pigmentation and RPE65-IR, uniformly express
the neural stem cell marker Musashi-1 in the cytoplasm7, we
hypothesised that adult newt RPE cells are reprogrammed into mul-
tipotent cells, which give rise to both a new NR and RPE. We termed
these RPE-derived cells ‘stem-like cells’6. However, the multipotency
of these stem-like cells has not yet been determined.
In this study, we evaluated adult newt RPE-derived stem-like cells
using immunohistochemistry and single-cell qPCR and obtained
valuable insight into the similarities and differences between retinal
disorders and regeneration.
Results
Identification of newt Pax6 as a probe for multipotent cells that
can generate both the NR and RPE.We predicted that RPE-derived
stem-like cells would be comparable to cells capable of differentiating
into both the NR and the RPE, such as (i) neuroepithelial cells of the
early optic vesicle, (ii) retinal stem/progenitor cells of the pro-NR
region in the optic vesicle (late stage)/cup, (iii) cells of the CMZ in
embryonic/larval eyes, (iv) cells of the pro-RPE region in the optic
vesicle (late stage)/cup, or (v) immature/uncommitted RPE cells in
the embryonic/larval eyes, on the basis of evidence from develop-
mental and regeneration biology8–10. To test this hypothesis, we
selected the transcription factor Pax6 as a probe because this factor
is commonly expressed in these cells and its roles are highly
conserved in vertebrates11. In addition, in studies of embryonic/
larval animals, Pax6 has been recognised as a master control gene
for the transdifferentiation/fate-switching of RPE cells into NR
cells8,12.
In the C. pyrrhogaster newt, four transcript variants (Cp-Pax6-LL,
-LS, -SL and -SS) from the same locus have been reported13. However,
these variants have not been functionally validated, and we were
unable to preclude the presence of paralogues because the newt gen-
ome (,20 Gbp) has not yet been sequenced. Thus, for the first time,
we applied a transgenic protocol that was established for the newt14 to
knockdown all four Pax6 variants by RNA interference with shRNA,
and we confirmed their conserved function in eye morphogenesis. In
a severe case with shRNA-2, the larvae demonstrated a small head
with no eyes (Fig. 1a–c and Supplementary Fig. 1). Consequently, we
concluded that this locus functionally corresponds to Small eye (Sey)
Pax615.
Thus far, the expression patterns of Pax6 during newt eye develop-
ment and retinal regeneration have been studied by histology13,16,17.
However, the cRNA probes or antibodies used in these studies were
not able to discriminate canonical paired-homeodomain type Pax6
(including the four Pax6 variants in the newt) from paired-less var-
iants, which should also be expressed in the eye tissues18. In addition,
background noise in eye tissues that contain early regenerating ret-
inas is too high to discriminate signals17. Therefore, we screened an
antibody (AD2.38) that is specific to canonical Pax6 (Fig. 1c and
Supplementary Fig. 2a), and improved the immunohistochemistry
protocols (Methods). Finally, we successfully compared the express-
ion patterns of Pax6 between developing and regenerating retinas.
In embryonic/larval development, as anticipated, the expression
patterns of Pax6 were highly conserved (Fig. 1d, e and
Supplementary Fig. 2b–d). Pax6-IR was observed in the following:
(i) the neuroepithelial cells of the early optic vesicle (St. 23); (ii) the
pro-NR region in the optic vesicle (late stage; St. 24)/cup (St. 27); (iii)
retinal progenitor cells in immature retinas (St. 30); (vi) the CMZ; (v)
the pro-RPE region in the optic vesicle (late stage; St. 24)/cup (St. 27);
(vi) immature RPE cells that containedmelanin pigments but did not
show RPE65-imminoreactivity (St. 30); and (vii) some types of NR
cells (ganglion, amacrine, horizontal and Mu¨ller glia cells).
Pax6 immunoreactivity was not detected in RPE-derived stem-
like cells but was detected in cells forming the pro-NR layer. In
adult retinal regeneration, if RPE-derived stem-like cells are
comparable to cells in the optic vesicles/cups or to immature RPE
cells, they should express Pax6. However, unexpectedly, Pax6-IR was
first detected in only a small number of RPE-derived cells (mean:
11.8%, n59) at Stage E-1 (day 10 po) when almost all of the cells
(mean: 97.2%, n58) had entered the cell cycle (Fig. 2a–c). This
became obvious in subsequent days when RPE-derived cells were
segregated into two rudimentary layers (pro-NR and pro-RPE). At
Stage E-2 (day 14 po), Pax6-IR was almost uniformly observed along
the pro-NR layer, but its expression was very sparse in cells located
along the pro-RPE layer (Fig. 2d). Then, Pax6-IR in the pro-RPE
layer became undetectable by Stage E-3 (day 19 po, Fig. 2d). By
contrast, the thickness of the Pax6-IR1 pro-NR layer or
regenerating NR increased, and as cell differentiation proceeded,
the number of Pax6-IR1 retinal progenitor cells decreased, while
the Pax6-IR1 NR cells appeared in the following order: ganglion
cells (St. I-1)R amacrine cells (St. I-2)R horizontal cells (St. I-3)
RMu¨ller glia cells (St. I-3 to L-1). Thus, together with our previous
findings5,6, after Stage E-3, the process of retinal regeneration seemed
to recapitulate embryonic retinal development.
Consequently, the RPE-derived cells at Stage E-1 were most likely
not comparable to the cells we had predicted. In addition, two cell
populations seemed to appear abruptly in the RPE-derived cells
between Stages E-1 and E-2, forming the pro-NR layer (Pax6-IR1)
and the pro-RPE layer (Pax6-IR-) by Stage E-2.
Single-cell qPCR revealed that adult newt RPE cells express muti-
potent properties while preserving their original characteristics.
Next, we investigated whether RPE-derived cells express other stem
cell markers. To do so, a single-cell qPCR technique was adopted
because there are few antibodies available for this model animal, and
in situ hybridisation seems empirically to have insufficient sensitivity
(or signal to noise ratio) for detecting low concentrations of mRNAs
whose transcription has started. Candidate genes were identified
using a newt de novo assembly transcriptome database (IMORI,
http://antler.is.utsunomiya-u.ac.jp/imori/), which we concurrently
established for the study of early processes of retinal regeneration
(Nakamura, K. et al., unpublished). Here, we examined three
pluripotency factors (c-Myc, Klf4 and Sox2)19, the microphthalmia
factor Mitf20, and Pax6. Recent in vitro studies in mammals have
suggested that a set of pluripotency factors can induce the cell type
switching of RPE cells into multipotent cells21. However, we must
note that the expression of Oct4 or Nanog, pluripotency factors that
can generate induced pluripotent stem (iPS) cells in mammals19,21,
was not detected in the early processes of retinal regeneration
(Nakamura, K. et al., unpublished). In other vertebrates, Mitf is
known to be expressed in (i) the neuroepithelial cells of the early
optic vesicle, (ii) cells of the pro-RPE region in the optic vesicle (late
stage)/cup, and (iii) immature/uncommitted RPE cells in
embryonic/larval eyes (Supplementary Table 1). In those cells, it
has been suggested that loss of function of Mitf is sufficient to
induce their fate-switching into the NR20.
We isolated RPE cells (day 0 sample) and RPE-derived cells (day
10 sample) from intact and retinectomised eyeballs, respectively,
www.nature.com/scientificreports
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Figure 1 | Identification of newt Pax6 as a probe for multipotent cells that can generate both the NR and RPE. (a–c), Functional identification by
transgenesis. Knockdown of Pax6 was carried out with two Pax6 shRNAs, which were designed to degrade all four transcript variants (LL, LS, SL, and SS)
of Pax6 (Supplementary Fig. 1a). Each was inserted into a transgene construct, which enables the expression of both a reporter mCherry and shRNA in the
whole body of the animal (a). Control shRNA was designed from a region in the newt crystallin promoter. Pax6 shRNAs affected eye morphogenesis as
well as body growth along the anterior-posterior axis (b). shRNA-2 exerted a more severe effect than shRNA-1 (Supplementary Fig. 1b). In the case of
shRNA-2 (Pax6 KD in b), 50% of larvae that showed strong mCherry fluorescence lacked eyes (arrowheads). Western blot demonstrated the knockdown
of Pax6 (c). Two bands corresponding to Pax6-SL (,47 kD) and -SS (,45 kD) isoforms were detected in the control lane (Control shRNA; larvae at St.
35–38) but not in the Pax6KD lane (Pax6 shRNA-2; eye-less larvae at the same age). The bands near 75 kD represent ubiquitous proteins that were stained
under the current experimental conditions. (d), (e), Expression patterns of Pax6 (d) and RPE65 (e) during retinal development. Pax6 was expressed,
almost uniformly, in both the prospective-NR (pro-NR) and -RPE (pro-RPE) regions in the optic cup (St. 27) as well as in cells in the early (St. 23) and late
(St. 24) optic vesicle (OV). Pax6 expression in both progenitor layers started to decrease from the central area near the optic stalk (OpS) as the eye grew.
On the NR side, Pax6 expression increased in certain types of cells as they differentiated in the following order: ganglion/amacrine cells (St. 30)R
horizontal cells (St. 37)RMu¨ller glia cells (St. 40). It should be noted that Mu¨ller glia cells in this animal expressed Pax6 even in the mature NR
(Supplementary Fig. 2). On the RPE side, pigmentation occurred in most areas by St. 28–29. Pax6 expression started to decrease from the central area
around St. 30 when the cells there were still proliferating. Proliferation stopped at around St. 32 when the presumptive outer nuclear layer (photoreceptor
layer) appeared on the NR side. RPE65, a maturation marker of RPE cells, initiated expression from the corresponding area at St. 32 (red in e). Short
vertical lines: borders of NR and RPE; arrowheads in St. 30: nuclei of prospective RPE cells; pink arrow in St. 37: presumptive outer nuclear layer; pink
arrowheads and black arrows in St. 40: horizontal cells andMu¨ller glia cells; and green arrow in St. 43: presumptive inner plexiform layer; L: lens. Tissues
were bleached except for tissues in St. 43. DAPI: a nuclear marker. Scale bars: 5 mm for larvae in b and 100 mm for the other panels.
www.nature.com/scientificreports
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which were collected from animals at day 10 po (Fig. 3a). Then, we
selected solitary cells manually under a dissecting microscope, fol-
lowed by cDNA synthesis and qPCR. For the day 0 sample, RPE cells
were identifiable by their characteristic morphology (i.e., polarity
with a pigmented apical region and a non-pigmented basal region
containing the nucleus). However, in the day 10 sample, visual cell
identification was difficult because of potential contamination of
pigmented cells of different origins5. Therefore, only cells that
resembled normal RPE cells were selected, i.e., a fraction of the
RPE-derived cells whose morphological change was slightly delayed.
We first carried out qPCR analysis using 100 harvested cells
(Fig. 3b). Pluripotency factors (c-Myc, Klf4 and Sox2), Mitf and
Pax6 were consistently detected in the day 10 samples but never in
the day 0 samples (n $ 4). Although RPE65 was detected in both
samples (n54), the relative expression levels of RPE65 were not
significantly different between the samples. We next performed
qPCR with single-cell samples (Fig. 3c, d). On day 0, as observed
from 100 single-cell samples, none of the genes examined were
detected. However, in a total of 17 cells, RPE65 was detected
(RPE651 cells). By contrast, on day 10, from a total of 19 RPE651
cells, 13 cells (68%) showed the expression of target genes (Fig. 3c),
although the combination of detected genes varied between indi-
vidual cells (day 10 in Fig. 3d).
Such a fluctuation in the detection of each target gene in the day 10
samples may be explained by the probability of reverse transcription
(RT) under a condition of low concentrations of mRNA (the sub-
strate of the RT polymerase), which should be true for the current
single-cell samples. That is, the detection rate should depend on the
Figure 2 | Expression pattern of Pax6 during retinal regeneration. (a–c), Stage E-0 to E-1. RPE cells that were tracked by RPE65-immunofluorescence
(red) did not show Pax6-IR (brown) until day 10 after retinectomy (a). In this period, RPE cells lost their epithelial structure to form cell aggregates (St. E-
1). Pax6-IRwas first detected only in a small number of cells (arrowheads). AWestern blot supported the expression of Pax6 at day 10 (b). Protein samples
were prepared fromRPE-choroid tissues collected from the posterior halves of retinectomised eyeballs on days 0 and 10. The band for day 10 corresponds
to the LL isoform (,49 kD). b-Actin: internal control. The cell count in the tissue sections from three different eyes at day 10 demonstrates that almost all
RPE-derived cells at this stage had entered the cell-cycle, as revealed by PCNA-IR, but they did not express Pax6 (c). The ratio of Pax61 cells to RPE651
cells was significantly lower than that of PCNA1 cells to RPE651 cells (P50.0005, n: number of sections; Mann-Whitney U test). (d), Stage E-2 to L-1.
When the two rudimentary layers formed (St. E-2) at approximately day 14, Pax6-IR became almost uniformly localised along the inner layer (pro-NR
layer), but there were only in a small number of nuclei (arrowheads) along the outer layer (pro-RPE layer). Pax6-IR in the pro-RPE layer became
undetectable by day 19 when constituent cells mostly exit the cell-cycle5 (St. E-3). By contrast, cells in the pro-NR layer (or the regenerating NR), which
continue to proliferate5, sustained Pax6-IR. In the ensuing retinal regeneration, the thickness of the regenerating NR increased, and, as cell differentiation
proceeded, the number of progenitor cells decreased, while Pax6-IR NR cells appeared in the following order: ganglion/amacrine cells (pink arrows, St. I-
1)R horizontal cells (pink arrowheads, St. I-3)RMu¨ller glia cells (arrows, St. I-3 to L-1). Thus, after the two rudimentary layers had formed, the process
of retinal regeneration was similar to that of embryonic/larval retinal development. Green horizontal lines in St. E2 to I-1: borders of NR and RPE; pink
horizontal lines in St. I-2: width of the presumptive outer nuclear layer (ONL); green arrow in St. I-3: presumptive inner plexiform layer (IPL); panels
labelled with ‘c’: negative control;OPL: outer plexiform layer; INL: inner nuclear layer;GCL: ganglion cell layer. Scale bars: 40 mm for a and c and 100 mm
for d.
www.nature.com/scientificreports
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concentration of mRNA under this condition. As a result, all data
were combined (n519), and the detection rates of target genes
(Fig. 3c) showed a similar pattern to that (c-Myc . Klf4 . Sox2;
Mitf . Pax6) of their relative expression levels obtained in the 100
single-cell samples (Fig. 3d). These observations suggest thatmRNAs
of all the target genesmay be present in a single day 10 cell at different
concentrations. It is noteworthy that one particular cell (D10 Single
#18) expressed all target genes (Fig. 3d). Taken together, these find-
ings indicate that RPE cells are reprogrammed into a unique multi-
potent state.
To visualise the expression of these multipotency factors,
immunohistochemistry was attempted. We searched for antibodies
for c-Myc, Klf4, Sox2 and Mitf in this species, and we finally found a
good antibody for Sox2 (Supplementary Fig. 3a). In both the devel-
oping and adult eyes, the patterns of Sox2-IR were consistent with
those reported in other vertebrates22–24; Sox2-IR was observed in (i)
the neuroepithelial cells of the early optic vesicle (St. 23), (ii) the pro-
NR region in the optic vesicle (late stage; St. 24)/cup (St. 27), (iii)
retinal progenitor cells in the immature retina (St. 29, 30, 32), (vi) the
CMZ, and (v) some types of NR cells (amacrine andMu¨ller glia cells)
(Supplementary Fig. 3b–d and Supplementary Table 1).
Unexpectedly, but interestingly, during adult retinal regeneration,
the patterns of Sox2-IR expression until Stage E-3 were almost the
same as those for Pax6 (Fig. 3e). Sox2-IR became detectable in a small
number of RPE-derived cells at Stage E-1 (day 10 po) and was clearly
observed along the pro-NR layer at Stage E-2 (day 14 po).
Figure 3 | Adult newt RPE cells newly express multipotent properties upon retinectomy while preserving their original characteristics. (a–d), Single-
cell qPCR. Normal RPE cells (day 0) and RPE-derived cells (day 10) were isolated from the control and retinectomised eyes of the same animal at day 10
after retinectomy (a). In each-day sample, RPE cells were identified by their morphological characteristics (cells with a pigmented apical part and a non-
pigmented part with the nucleus), and solitary cells were manually selected under a dissecting microscope. First, 100 cells on days 0 and 10 were
harvested into different tubes to prepare each cDNA sample, and real-time PCR was carried out using these samples for RPE65, c-Myc, Klf4, Sox2,Mitf,
Pax6 and Ef1a. A comparison of the expression levels of genes that compensated for Ef1a is shown in b. Numbers in parentheses represent the ratio of
detection (dominator: sample number). The same experiments were performed with one-cell samples. The cumulative detection rates of genes in
RPE651 cells are shown in c. Raw data tables mentioning the Cq values are shown in d. Horizontal bars indicate no detection. e, Sox2
immunohistochemistry in Stage E-0 to E-2 regenerating retinas. Tissues were bleached. Sox2-IR was first detected in a small number of RPE-derived cells
at stage E-1 (arrowhead) and then along the inner rudimentary layer (pro-NR layer) at stage E-2. Green horizontal lines in stage E-2: borders of the pro-
NR and pro-RPE layers. Scale bars: 50 mm for a and e. f, Summary of the current results and proposed mechanism.
www.nature.com/scientificreports
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Discussion
In conclusion, the results of our experiments are summarised and
explained in Figure 3f. In the adult newt, the RPE is the sole cellular
source for regeneration of missing NR in the posterior eye. The adult
newt RPE is a highly specialised monolayer, similar to that in other
vertebrates5. We can exclude the possibility that the intact RPE con-
tains ‘retinal stem/progenitor cells resembling RPE cells (or RPE65-
IR1)’ that function to regenerate the NR because RPE-mediated
retinal regeneration after retinectomy could be repeated more than
three times (the cellular source for the new NR was not exhausted;
our unpublished observation) and the RPE was not replaced by
tissues other than the RPE itself5. Moreover, the current single-cell
qPCR results revealed that intact RPE cells do not express retinal
stem/progenitor markers.
Upon retinectomy, RPE cells are detached from each other as well
as the basement membrane, lose their epithelial characteristics to
become cell aggregates, and enter the S-phase of the cell cycle.
These RPE-derived cells are segregated into two rudimentary layers
(the pro-NR and pro-RPE layers) with correct polarity, eventually
regenerating a new NR while renewing the RPE. Our previous study
demonstrated that almost all of the RPE-derived cells that entered the
S-phase of the cell-cycle on day 10 po (Stage E-1) uniformly
expressed the neural stem-cell marker Musashi-1 in the cytoplasm,
and the expression of Musashi-1 was sustained along the pro-NR
layer at day 14 po (Stage E-2) but was down-regulated along the pro-
RPE layer7. These observations led us to hypothesise that RPE cells
are reprogrammed into multipotent cells by Stage E-1 and are then
differentiated into two cell populations, which may depend on their
surrounding microenvironment (or niche), between Stages E-1 and
E-2.
In this study, we found that RPE cells newly express c-Myc, Klf4,
Sox2, Mitf and Pax6 while retaining their expression of RPE65, as
observed for both the mRNA and protein levels. These cells are thus
converted into a unique state of multipotent cells (termed RPESCs
here for convenience; Figure 3f). Moreover, the pluripotency factors
c-Myc, Klf4 and Sox2 may reprogram or initialise RPE cells, as
demonstrated in in vitro studies in mammals21, whereas Oct4 and
Nanog are unlikely to participate in this system, as observed in chick
RPE reprogramming into the NR10 as well as in other regeneration
systems in adult newts25. Our review of the gene expression patterns
during eyemorphogenesis (Supplementary Table 1) suggests that the
cells that express c-Myc, Klf4 and Sox2, as well as Pax6 and Mitf, are
only those in the early optic vesicle. Hence, the adult newt RPESCs
seem to correspond to the neuroepithelial cells of the early optic
vesicle, which generate both the NR and RPE. In other words, adult
newt RPE cells seem to dedifferentiate in nature. Our previous study
suggested the presence of RPE65 expression and melanin pigments
in RPE-derived cells for a longer period (,20 days after retinect-
omy), which may be due to their slow degradation or excretion5.
However, both the Pax6 and Sox2 antibodies, which clearly
labelled optic vesicle cells, did not label RPESCs. In the tissue of
Stage E-1 (day 10 po), although single-cell qPCR detected Pax6
and Sox2 mRNA expression even in RPE-derived cells that had not
reached a standard progression with a cell shape resembling that of a
normal RPE cell, the antibodies labelled only the advanced cells that
formed the pro-NR layer. Thus, perhaps either the level of protein
expression in RPESCs is very low or some type of modification
occurs to both proteins to prevent the antibodies from accessing
the corresponding epitopes. However, the latter explanation can be
excluded because we detected Pax6 protein expression by Western
blotting (Fig. 2b). If the former explanation is true, at least with
respect to Pax6 and Sox2, adult newt RPESCs may not require
expression levels equivalent to those in optic vesicle cells to behave
as multipotent cells.
Establishing a primary pattern of tissue organisation at an early
stage of regeneration is essential for the reconstruction of different
tissue types, with the correct polarity, from a single cell source. Pax6/
Sox2-IR1 cells appeared among RPESCs from Stage E-1 to E-2,
which formed the pro-NR layer (Fig. 3f). By contrast, the cells with
no immunoreactivity formed the pro-RPE layer. Because mitotic
figures were clearly observed in RPE-derived cells between Stages
E-1 and E-2, these cell populations seemed to be arranged according
to the correct polarity (inside: cells forming the pro-NR; outside: cells
forming the pro-RPE), and their proliferation was activated during
this period.
However, this process was imperfect, as a small number of Pax6/
Sox2-IR1 cells were irregularly distributed in the pro-RPE layer
(termed ‘displaced pro-NR cells’ here). Interestingly, because the
displaced pro-NR cells participated in the renewal of the RPE,
RPESCs directed towards regeneration of the NR seem to retain
the ability to re-differentiate into the original cell type. Pax6/Sox2-
IR in displaced pro-NR cells disappeared between Stages E-2 and E-3,
whereas along the pro-NR layer, Pax6/Sox2-IR seemed to be sus-
tained until Stage I-1 when neuronal cell differentiation began, sug-
gesting that opposite regulation of Pax6/Sox2 expression promotes
the renewal of the RPE and regeneration of the NR.
Considering their morphological and physiological changes5,6, the
pro-NR and pro-RPE layers seem to be comparable to the pro-NR
and pro-RPE regions in the optic vesicle (late stage)/cup. However,
unlike the pro-RPE region (Pax6-IR1/Sox2-IR-) in the optic vesicle/
cup, the pro-RPE layer (Sox2-IR-) was seldom labelled with the Pax6
antibody. During retinal development, Pax6-IR seemed to be regu-
lated in association with cell differentiation. As for the RPE, Pax6-IR
observed in immature cells disappeared as cells matured while
expressing RPE65 (Fig. 1d, e). In retinal regeneration, RPE65-IR
reappeared along the renewing RPE between Stages I-3 and L-1
(day 28 po)5. Thus, compared to the developmental process, the
disappearance of Pax6-IR in the renewing RPE seems to occur far
earlier than the maturation of the RPE, implying that there are dif-
ferent regulatory mechanisms for Pax6 between development and
regeneration. As discussed for RPESCs, the process of RPE renewal
might not require Pax6 at levels equivalent to those for development
of the RPE. Interestingly, a published report indicated that another
transcription factor, Otx2, which is required for RPE cell differenti-
ation during eye development, might be involved in themaintenance
and specification of RPE cells during retinal regeneration26.
Taken together, to the best of our knowledge, this study provides
the first set of evidence at the single cell level for the natural repro-
gramming of somatic cells for the regeneration of body parts in the
newt. Furthermore, our results reveal that adult newt retinal regen-
eration has many important issues that require further investigation,
such as reprogramming, multipotency, cell specification, niche, and
tissue patterning as well as EMT and proliferation. However, to apply
this knowledge tomedicine, the extent to which this system is unique
to this animal must be evaluated. In humans, upon retinal injury,
RPE cells lose their epithelial characteristics and acquire the ability to
migrate and proliferate, transforming intomesenchymal cells such as
myofibroblasts3,4. In PVR, the RPE-derived myofibroblasts are a
major component of the epiretinal membrane that covers the wound
of the NR, although the membrane eventually contracts together
with the NR, leading to loss of vision. Thus, the initial response of
human RPE cells to retinal injury resembles that of adult newt RPE
cells. However, this phenomenon is categorised as EMT because the
fate of the RPE cells is mesenchymal tissue rather than NR3. Recent
studies in stem cell biology have reported that human RPE cells pass
through a multipotent state during EMT, and in vitro studies suggest
that RPE-derived proliferative cells in humans are capable of expres-
sing C-MYC and KLF4 as well as PAX6 andMITF (but not OCT4 or
NANOG) and behave as stem cells (termed RPESCs)4. Interestingly,
in human RPESCs, SOX2 expression seems to be negligible4, which is
different from that observed in adult newt RPESCs. Because Sox2 is
considered a decisive factor for neural competence in the retina23,24,
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this factor, and possibly its co-factors, may be important for directing
RPESCs toward retinal regeneration. This study revealed that human
and newt RPESCs show close similarities in their intrinsic properties.
In the future, comparative/integrated studies of these regeneration-
competent and -incompetent models at the molecular level, such as
through comprehensive single-cell transcriptome analysis, would
likely provide essential factors for inducing retinal regeneration in
human RPESCs as well as understanding the molecular mechanisms
of adult newt retinal regeneration.
Methods
All experiments were carried out in accordance with the guidelines approved by the
University of Tsukuba Animal Use and Care Committee (AUCC).
Animals.The Japanese fire bellied newt,Cynops pyrrhogaster, was used for this study.
Fertilised eggs for transgenic and developmental studies were obtained from the adult
Toride-Imori, a race of this species that was originally captured fromKamogawa City,
Chiba Prefecture, Japan, and were stocked/cultured in the laboratory (Univ. of
Tsukuba) and at ‘Imori-no-Sato’ (Toride City, Ibaraki Prefecture, Japan; http://imori-
net.org/)14. In brief, before the experiments, males and females (total body length:
male,,9 cm; female, 11–12 cm) were transferred into a two-aquarium-tank (TAT)
system and reared under a semi-natural condition, allowing them to display courtship
behaviour, which was followed by the delivery of a spermatophore from the male to
the female. To collect fertilised eggs, female newts were injected subcutaneously in the
abdominal region with 50 ml (30 U) of gonadotropin (Gonatropin 3000; Asuka
Pharmaceutical, Tokyo, Japan) every other day. Wild-type embryos and larvae were
reared as described previously14. The developmental stage was determined according
to previous criteria14.
For the regeneration study, adult newts of other races (captured from Kagawa,
Okayama, or Miyagi Prefecture) that were purchased from a supplier (Aqua Grace,
Yokohama, Japan) were also used. These newts were reared in containers at ,18uC
under natural light until the experiments were performed. They were fed daily with
frozen mosquito larvae (Akamushi; Kyorin, Himegi, Japan), and the containers were
kept clean at all times14.
Transgenesis.An I-SceI transgenic protocol for the newt14 was applied to knockdown
Pax6. A transgene construct pCAGGs-mCherry-shRNA (Sce) (Fig. 1a) was prepared
by modifying pCAGGs-EGFP (Sce)14 with conventional molecular cloning
techniques; a reporter EGFP was replaced with mCherry to minimise
autofluorescence, and then a sequence encoding shRNAwas inserted, with restriction
enzymesMun I (59 end) and Hpa I (39 end), in between the mCherry and the polyA
signal. Two shRNAs were designed to degrade all four spliced variants of Pax6
(Supplementary Fig. 1). A control shRNA was designed using a region (319–342) in
the newt crystallin promoter (DDBJ/GenBank Accession #: AB113881). Preparation
of single-cell embryos, microinjection of the construct [injection volume: 10 ml/
embryo; contents: 200 ng of the DNA construct, 0.5 U of I-SceI (R0694S; New
England Biolabs Japan, Tokyo, Japan), 1x I-SceI buffer, and 0.01% phenol red], and
rearing of the injected animals were performed according to previously published
protocols14.
Surgical operations. Surgical removal of the NR (retinectomy) was performed as
described previously5. In brief, after the adult newts were anesthetised in a 0.1%
FA100 (4-allyl-2-methoxyphenol; DS PharmaAnimal Health, Osaka, Japan) solution
in the dark at room temperature (RT, ,22uC) for 2 h, the dorsal half of the left eye
was cut open along the position that was slightly below the boundary between the
cornea and sclera, and the NR was carefully removed together with the lens. At this
time, the retinal margin containing the ora serrata (the tissue harbouring the retinal
stem/progenitor cells) was also removed. After the operation, the eye flap, consisting
of the iris and cornea, was carefully placed back in its original position. The operated
animals were allowed to recover in a moist container and were then reared in an
incubator (,22uC; 12 h:12 h day:night cycle) until use. The stage of retinal
regeneration and corresponding day po were determined according to previous
criteria5 (Supplementary Movie 1).
Collection of eyeballs and preparation of tissue samples. Newts were sacrificed
under anaesthesia to minimise suffering5. To collect eyeballs, the animals were
decapitated, and the eyeballs were carefully enucleated with fine scissors and forceps.
In some experiments, the eyeballs were first dissected into the eye cups (posterior half
of the eyeball), and then the NR (in the case of normal eyeballs) or the RPE-choroid
tissues were collected17. For embryos/larvae, the whole body served as a tissue sample.
Antibodies. The primary and secondary antibodies used for immunoblotting and
immunohistochemistry were as follows: for Pax6, mouse monoclonal anti-Pax6
antibody (15100; AD2.38, sc-32766; Santa Cruz Biotechnology, TX 75220, U.S.A)
and biotinylated goat anti-mouse IgG antibody (15500; Vector Laboratories, CA
94010, U.S.A); for Sox2, rabbit anti-Sox2 antibody (15660; ab97959; Abcam,
Cambridge, U.K.) and biotinylated goat anti-rabbit IgG antibody (15500; Vector
Laboratories); for RPE65, mouse monoclonal anti-RPE65 antibody (15500;
MAB5428; Millipore, Darmstadt, Germany) and tetramethylrhodamine-conjugated
goat anti-mouse IgG antibody (15200; T2762; Life Technologies, MD 20850, U.S.A);
and for PCNA, human autoantibody to PCNA (15500; gift from Dr. T. Saito)5 and
Alexa Fluor 488-conjugated goat anti-human IgG (151,000; A-11013; Life
Technologies). For the negative control, mouse or rabbit antibodies (IgG) with no
specific reactivity to newt tissues (e.g., anti-dsRed antibody; 632543 or 632496;
Clontech, CA 94043, U.S.A) were applied, instead of the primary antibody, at the
same concentration of IgG.
Immunoblotting. Protein sample preparation and immunoblotting were performed
as described previously5,17. In brief, tissue samples (i.e., embryos/larvae or eye tissues)
were collected in chilled PBS and dissolved in lysis buffer [25 mM Tris, 150 mM
NaCl, 1 mM EDTA?2 Na, 1% Igepal CA-630, 1% proteinase inhibitor cocktail (P-
8340, Sigma,MO63103, U.S.A), 1% sodiumdeoxycholate, and 0.1% SDS, pH 7.5] at a
concentration of one tissue sample/7 ml lysis buffer. The supernatant was mixed with
an equal volume of 23 sample buffer [100 mM Tris-HCl (pH 6.8), 4% SDS, 20%
glycerol, 0.01% (w/v) bromophenol blue (Wako, Osaka, Japan), and 10% b-
mercaptoethanol (Sigma)], boiled for 5 min, and then stored at 220uC until use.
Proteins were separated on a 10% gel (456–1033; Mini-Protean TGX Gels; Bio-Rad,
CA 94547, U.S.A) by SDS-PAGE and transferred onto a PVDF membrane (Immun-
Blot PVDF membrane for protein blotting, Bio-Rad). The blots were conventionally
labelled with the primary antibody and visualised with the biotinylated secondary
antibody and an ABC/DAB system (Vectastain ABC Elite kit, DAB substrate kit,
Vector Laboratories).
Immunohistochemistry. Tissue samples were fixed in 2% paraformaldehyde/0.2%
picric acid in PBS (pH 7.4) at 4uC for different periods [embryos/larvae, 8 h; normal
and retinectomised (day 5 to 45 po) eyeballs, 5 h; eyeballs immediately after
retinectomy (i.e., day 0 po), 2 h] and then cryosectioned transversely at a thickness of
,20 mm5.
Immunolabelling of tissue sections was performed as described previously5 with
some modifications. For eyeball sections, an antigen retrieval step was added before
the process of immunolabelling; after the slits were made along the inside margin of
the cornea and sclera to separate the iris and retinal tissues from those connective
tissues (bymanipulating a blade under a dissectingmicroscope), eyeball sections were
rinsed in PBS for 15 min, incubated in a sodium citrate buffer (10 mMsodium citrate,
0.05% Tween 20, pH 6.0) at 90uC for 10 min, and then rinsed in PBS twice for 5 min
each. During incubation in the sodium citrate buffer, the corneal and scleral tissues
became coiled and dissolved into the buffer solution. This treatment clearly decreased
the background staining of the tissues (possibly due to some blood-related content in
the choroid) while sustaining immunoreactivity, which increased the signal to noise
ratio.
The localisation of Pax6 and Sox2 was determined using a previously developed
immunoperoxidase labelling procedure with the ABC/DAB system5, and RPE65 and
PCNAwere evaluated with an immunofluorescence procedure5. In the case of double
labelling with Pax6 and RPE65 antibodies (both are mouse monoclonal antibodies),
immunoperoxidase labelling of Pax6 without the DAB reaction was followed by
immunofluorescence labelling of RPE65. Finally, Pax6-IR was visualised with DAB.
In some experiments, the melanin pigments of cells were bleached to reveal the
immunoreactivity5. After labelling, cell nuclei were counterstained with DAPI
(1550,000; D1306; Life Technologies).
Cell isolation and cDNA synthesis. For single-cell qPCR, both the right (intact) and
left (retinectomised) eyeballs of animals at day 10 po were used (Fig. 3a). In
particular, the right eyeballs were used for the day 0 po sample containing intact RPE
(stage E-0), and the left eyeballs were used for the day 10 po (stage E-1) samples.
For one round of the experiment, three animals were sacrificed under anaesthesia,
and the right and left eyeballs were collected in different plastic dishes (Falcon 35-
3001; Becton Dickinson, NJ07417, U.S.A) that were filled with RNase-free PBS on ice.
The right eyeball (day 0) was dissected into the eye cup, the NR was removed, and
then the RPE sheet together with the choroid tissues was isolated by separating these
from the sclera using a fine pin and forceps (left-hand pathway in Fig. 3a)17.
Subsequently, the left eyeball (day 10) was carefully opened from the wound at the
time of retinectomy using a fine pin and scissors, the anterior part of the eyeball
containing the iris and ciliary marginal zone was carefully removed, and RPE-derived
cells in the posterior eye were collected together with the choroid tissues in the same
manner as for the right eyeball (right-hand pathway in Fig. 3a). After as many blood
cells in the choroid were removed as possible by shaking the samples in the dish, three
samples for each day were transferred into different 15-ml tubes containing 1 ml of
elastase (1 mg/ml; Porcine pancreas; Ref: 11027891001; Roche Diagnostics Japan,
Tokyo, Japan) in EDTA solution (inmM: 115 NaCl, 3.7 KCl, 10 EGTA, 18 D-glucose,
10 HEPES, and 0.001% phenol red, pH 7.5 adjusted with 0.3N NaOH) with a 3.5 ml
transfer pipette (Sarsted, D-51588 Nu¨mbrecht, Germany). The samples were then
incubated for 90 min at 28uC. The tissue samples were rinsed with a chilled newt
saline solution (in mM: NaCl, 115; KCl, 3.7; CaCl2, 3; MgCl2, 1; D-glucose, 18; and
HEPES, 5; pH 7.5 adjusted with 0.3N NaOH) several times and then dissociated by
gentle trituration with the transfer pipette. The cell suspension was transferred into a
1% agarose-coated 35-mmplastic dish (Falcon 35-3001) that was placed on ice. These
trituration and cell collection steps were repeated 5–6 times.
cDNA synthesis and pre-amplification were carried out, under conventional
nuclease-free conditions, using TaKaRa CellAmp Whole Transcriptome
Amplification Kits (Real Time) Ver.2 (code#: 3730; Takara, Otsu, Japan) according to
the manufacturer’s instructions. In brief, solitary RPE cells or RPE-derived cells,
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which were identified by their morphological characteristics (Fig. 3a), were picked up
from the dish using a microtip (703Y, Ina Optika, Osaka, Japan) attached to a
micropipette (set at 0.5 ml; Pipetman P20; Gilson, WI 53562-0027, U.S.A.) under a
dissecting microscope. For 100-cell qPCR analysis, 100 cells were transferred into a
PCR tube (No T-02F, Ina Optica) containing 50 ml of RNase-free PBS, and the cells
were settled on the bottom of the tube with centrifugation for 1 min at 3,000 g. After
the PBS in the tube was discarded, leaving behind,0.5 ml, a 4.5-ml reaction mixture
containing cell lysis buffer was added. For one-cell qPCR analysis, one cell (0.5 ml)
was directly transferred into the tube containing the 4.5-ml reaction mixture. In both
samples, cDNA synthesis was followed, and then the resulting cDNAs were amplified
non-selectively by PCR (95uC, 1 minR 50uC, 1 minR 72uC, 3 min: 1 cycle; 95uC,
30 secR 67uC, 1 minR 72uC, 3 min: 20 cycles; 72uC, 1 min). The amplified cDNA
samples were stored at 220uC until use.
Quantitative PCR (qPCR). The amplified cDNA samples were diluted 10x and then
used as a template for qPCR. qPCRwas performed using a LightCyclerHNano system
(Roche Applied Science, Penzberg, Germany) according to the manufacturer’s
instructions for the FastStart Essential DNA Green Master (Roche) or FastStart
Essential DNA Probes Master (Roche) for 45 cycles. For each gene examined in this
study, the DDBJ/GenBank accession number, primers, probes [selected from the
Roche Universal Probe Library (https://www.roche-applied-science.com)], and
expected size were as follows: Ef1a, AB00558, forward: cgtgacatgaggcagactgt, reverse:
tagaggccttctgggctgat, 100 bp; RPE65, AB095018, forward: tgctgctggaaaggatttga,
reverse: gctttctctgcatttctcttcac, probe#: 48, 95 bp; c-Myc, AB904156, forward:
ctcagaagaagaacaggatgacg, reverse: atccaggcttcctgccagtag, 101 bp; Klf4, AB904164,
forward: ggtcaagggctggttagtcc, reverse: tgaggaggacacttgatggc, 101 bp; Sox2,
AB074258, forward: gtttatggaggagggcacgg, reverse: acctgagggacatgatcagc, 119 bp;
Mitf, AB904165, forward: cgtagcaagatccgtgatgtc, reverse: cagcagttcatccgagcat,
probe#: 25, 78 bp; and Pax6, D88741, forward: tctgggcaggtattacgagac, reverse:
cgatcttgctcaccacctc, probe#: 58, 95 bp. The specificity of the PCR results was
confirmed by standard gel electrophoresis and DNA sequencing.
Data analysis. In the transgenic analysis, bright-light and fluorescence images of
embryos/larvae were acquired using a digital camera (C-5060; Olympus, Tokyo,
Japan) attached to a fluorescence stereomicroscope (Leica M165 FC; Leica
Microsystems, Wetzlar, Germany) with a filter set for mCherry (Exciter: XF1044,
575DF25; Emitter: XF3402, 645OM75; Opto Science, Tokyo, Japan). Embryos/larvae
with visible red fluorescence throughout the body were selected and then subdivided
into ‘weak’, ‘moderate’ and ‘strong’ on the basis of their fluorescence intensity. The
fluorescence intensity was estimated as the average luminance by analysing the
fluorescence images of the embryos/larvae that were acquired with a x40 objective
lens, using a function of Photoshop Extended CS5 graphics software (Adobe Systems,
CA 95110-2704, U.S.A.). Embryos/larvae with an average luminance value of 40–60
were categorised as ‘moderate’, and those with higher and lower values were
categorised as ‘strong’ and ‘weak’, respectively.
For the immunohistochemical analysis, bright light and fluorescence images of
tissue sections were acquired using a CCD camera system (DP73; cellSens Standard
1.6; Olympus) attached to a fluorescence microscope (BX50; Olympus).
In single-cell qPCR analysis, 100-cell qPCR for each gene, which was always run
simultaneously with day 0 and day 10 po samples, was repeated usingmore than four
sets of independently collected samples. The expression levels of each gene (i.e., the
levels of transcripts estimated from the Cq value) were compensated for Ef1a in the
same sample. For one-cell qPCR, samples in which RPE65was detected were used for
further analysis of gene expression.
Data are presented as a box plot graph (Fig. 2b) or as a bar graph showing themean
6 SEM (Fig. 3b). Significant differences were evaluated with the Mann-Whitney’s U
test or Sheffe’s test following the Friedman test. Figures were prepared using
Photoshop Extended CS5 (Adobe Systems). Image, brightness, contrast, and sharp-
ness were adjusted according to the journal’s guidelines.
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